Atkore's chart shows Bollinger Bands Narrowing, KDJ Death Cross, Bearish Marubozu

According to Atkore's 15-minute chart, the stock price fluctuations are decreasing in magnitude, as indicated by the narrowing of the Bollinger Bands. Furthermore, the KDJ Death Cross and Bearish Marubozu at 10/21/2025 15:15 suggest that the momentum of the stock price is shifting towards the downside, with a potential for further decreases. The sellers are currently in control of the market, and based on these technical indicators, there is a likelihood of continued bearish momentum.

MIRA Pharmaceuticals' stock price has shown notable volatility in recent weeks, with significant fluctuations driven by both positive and negative market sentiment. As of September 12, 2025, the company's stock price has been experiencing a decrease in magnitude, as indicated by the narrowing of the Bollinger Bands on Atkore's 15-minute chart MIRA Stock Price and Chart — NASDAQ:MIRA — TradingView^[1]. This narrowing suggests that the price fluctuations are becoming less pronounced, potentially signaling a period of consolidation.

Further analysis of the technical indicators reveals a KDJ Death Cross and a Bearish Marubozu at 10/21/2025 15:15, suggesting that the stock's momentum is shifting towards the downside . These indicators suggest that the sellers are currently in control of the market, which could lead to continued bearish momentum. This shift in momentum is a significant development for investors, as it indicates a potential for further decreases in the stock price.

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company, specializing in developing products to address unmet medical needs in pain management, depression, PTSD, and cognitive function . The company's stock price has shown a 20.00% increase over the last year, despite recent volatility . However, the company's earnings have been consistently negative, with a net income of −1.54 M USD in the last quarter .

Investors should closely monitor the company's financials and technical indicators to make informed decisions. While the narrowing Bollinger Bands and technical indicators suggest a period of consolidation, the company's earnings and cash runway are important factors to consider. The company's cash burn has been reduced by 8.1% in the past year, extending its cash runway to about 16 months .

In conclusion, MIRA Pharmaceuticals' stock price has shown significant volatility in recent weeks, with technical indicators suggesting a period of consolidation and bearish momentum. Investors should carefully consider the company's financials and technical indicators before making investment decisions.